Pecha Kucha Method Effects on Posttraumatic Growth and Psychological Resilience

April 18, 2023 updated by: Zülfünaz ÖZER, Istanbul Sabahattin Zaim University

Education Given to Breast Cancer Patients Receiving Chemotherapy With Pecha Kucha Method Effects on Posttraumatic Growth and Psychological Resilience

This study was planned to investigate the effect of the training given to breast cancer patients receiving chemotherapy with pecha kucha method on posttraumatic growth and psychological resilience.

Study Overview

Detailed Description

This study is a randomized controlled trial planned to investigate the effect of the training given to breast cancer patients receiving chemotherapy with the pecha kucha method on posttraumatic growth and psychological resilience.

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Istanbul, Turkey, 34034
        • Recruiting
        • Zülfünaz Özer
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients over 18 years of age
  • At least one course of adjuvant chemotherapy prior to treatment,
  • Literacy
  • Communicable patients
  • Patients who agreed to participate in the study

Exclusion Criteria:

  • With a psychiatric diagnosis,

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
Routine maintenance will be applied
Experimental: Pecha kucha method
Patients will be trained by pecha kucha method using computer with powepoint presentation.
Education with pecha kucha method

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post Traumatic Growth Inventory
Time Frame: Before the training
The 6-point Likert-type scale consists of 21 items and a 5-factor structure and is scored between 0-5. The total score that can be obtained from the scale varies between 0-105. The sub-dimensions of the scale are relationships with others, new possibilities, personal empowerment, spiritual change and appreciation of life. High scores on the scale indicate that posttraumatic growth is high.
Before the training
Post Traumatic Growth Inventory
Time Frame: 1 month after the training

The 6-point Likert-type scale consists of 21 items and a 5-factor structure and is scored between 0-5. The total score that can be obtained from the scale varies between 0-105. The sub-dimensions of the scale are relationships with others, new possibilities, personal empowerment, spiritual change and appreciation of life. High scores on the scale indicate that posttraumatic growth is high.

Before the training

1 month after the training

1 month after the training
Post Traumatic Growth Inventory
Time Frame: 2 month after the training

The 6-point Likert-type scale consists of 21 items and a 5-factor structure and is scored between 0-5. The total score that can be obtained from the scale varies between 0-105. The sub-dimensions of the scale are relationships with others, new possibilities, personal empowerment, spiritual change and appreciation of life. High scores on the scale indicate that posttraumatic growth is high.

Before the training

1 month after the training

2 month after the training
The Brief Resilience Scale
Time Frame: Before the training
The scale measures the psychological resilience of individuals. It is a 5-point Likert-type, 6-item, self-report measurement tool. High scores on the scale indicate high psychological resilience.
Before the training
The Brief Resilience Scale
Time Frame: 1 month after the training
The scale measures the psychological resilience of individuals. It is a 5-point Likert-type, 6-item, self-report measurement tool. High scores on the scale indicate high psychological resilience.
1 month after the training
The Brief Resilience Scale
Time Frame: 2 month after the training
The scale measures the psychological resilience of individuals. It is a 5-point Likert-type, 6-item, self-report measurement tool. High scores on the scale indicate high psychological resilience.
2 month after the training

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Zülfünaz Özer, PhD, Istanbul Sabahattin Zaim University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 10, 2023

Primary Completion (Anticipated)

May 10, 2023

Study Completion (Anticipated)

June 30, 2023

Study Registration Dates

First Submitted

April 18, 2023

First Submitted That Met QC Criteria

April 18, 2023

First Posted (Actual)

May 1, 2023

Study Record Updates

Last Update Posted (Actual)

May 1, 2023

Last Update Submitted That Met QC Criteria

April 18, 2023

Last Verified

April 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 2023/ 03- 24

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Psychological Resilience

Clinical Trials on Education with pecha kucha method

3
Subscribe